How does morphine affect prasugrel in patients with acute coronary syndrome?

In acute coronary syndrome, morphine delays and decreases exposure to prasugrel and its active metabolite, potentially reducing efficacy despite unknown clinical relevance; if morphine cannot be withheld and rapid P2Y12 inhibition is crucial, a parenteral P2Y12 inhibitor may be considered.